Product Description
Experience elite oncology care with Doxorubicin Hydrochloride Pegylated Liposomal Injection, available in Top strengths of 20 mg/10 ml and 50 mg/25 ml. Its grandiose, pharmaceutical-grade formulation ensures exquisite results in cancer therapy, offering savings in patient safety and efficacy. The deep red, translucent solution is ready to useno reconstitution requireddelivered by intravenous infusion only. Each glass vial is meticulously remarked with batch and expiry details, manufactured under strict GMP and regulatory authority approval. Pegylated liposomal technology prolongs circulation and reduces cardiotoxicity for optimal outcomes. Use under medical supervision only.
Exclusive Clinical Advantages and Applications
Doxorubicin Hydrochloride Pegylated Liposomal Injection stands out for its remarked excellence in treating a spectrum of malignancies, including breast and ovarian cancer, multiple myeloma, and AIDS-related Kaposis sarcoma. This exquisite formulation facilitates targeted chemotherapy and prolongs therapeutic action, offering additional benefits in advanced oncology settings. Its grandiose advantage lies in its ability to minimize cardiotoxicity while enhancing circulation time, making it a preferred choice for both specific and general oncological use under prescribed protocols.
Premium Sample Policy and Delivery Assurance
Elite packaging and swift delivery are hallmarks of our Doxorubicin Hydrochloride Pegylated Liposomal Injection. Sample policy is tailored to verified buyers, with premium quality assurance on every batch. Orders are processed upon receiving the purchase order, and prompt transportation ensures timely arrivals. Each glass vial is meticulously packed for safe transit under refrigerated conditions, maintaining efficacy and integrity. Customers can expect reliable support throughout the procurement process, with adherence to international packaging regulations for optimal satisfaction.
FAQs of Doxorubicin Hydrochloride Pegylated Liposomal Injection:
Q: How should Doxorubicin Hydrochloride Pegylated Liposomal Injection be administered?
A: This injection is strictly administered as an intravenous infusion by healthcare professionals. It is not suitable for intramuscular, subcutaneous, or oral routes.
Q: What are the primary benefits of pegylated liposomal delivery in this formulation?
A: The pegylated liposomal technology offers prolonged circulation, reduces exposure to cardiac tissue, and limits cardiotoxicity, thus enhancing the safety and effectiveness of chemotherapy.
Q: When should the injection not be used or mixed with other drugs?
A: The injection should never be mixed with other drugs or solutions, and extravasation should be avoided, as it may result in severe local tissue necrosis.
Q: Where are batch numbers and expiry dates located for quality assurance?
A: Batch numbers and expiry dates are clearly printed on each glass vial label, ensuring traceability and up-to-date usage.
Q: What storage requirements must be followed for this injection?
A: The product should be stored at temperatures between 2C and 8C, should not be frozen, and must be protected from light to maintain its integrity.
Q: How can customers place orders and expect delivery for this product?
A: Customers can place orders by submitting a formal purchase order. Delivery is managed with premium care, ensuring temperature-controlled transportation and secure packaging.